Dr Vasee Moorthy (BA MA BMBCh MRCP PhD) leads the Vaccine Development Team at WHO Initiative for Vaccine Research and is supported in this work by the WHO Product Development for Vaccines Advisory Committee. The portfolio of activities for the WHO Vaccine Development Team includes HIV, tuberculosis, malaria vaccines, RSV, Group A & B streptococcal disease, ETEC, Shigella and Norovirus, and WHO’s work in preclinical, and Phase 1-2 clinical vaccine evaluation for emerging pathogens including filoviruses and MERS-CoV. His team is also responsible for development of WHO TPPs and Preferred Product Characteristics documents. During the 2014-2016 Ebola emergency he led WHO’s work coordinating the acceleration of Ebola vaccine R&D into Phase 1 and Phase 2 vaccine trials in USA, Canada, Europe and Africa.
He is an infectious disease subspecialist physician with a clinical medicine degree (BMBCh) from the University of Oxford, a BA in Natural Sciences (University of Cambridge 1st class honours) and experience working as a general medical officer for the South African government in the 1990s in a rural district general hospital. He gained a PhD for clinical immunology studies conducted from 1999 to 2002 as part of malaria vaccine trials with DNA, and recombinant poxvirus vaccines in The Gambia. He has previously worked as a Senior Program Officer at PATH based in Bethesda, MD, with responsibility for clinical trials in USA, Europe, Africa and India. Dr Moorthy has been an employee of the World Health Organization since 2009, working in the Department of Immunization, Vaccines & Biologicals